Conmed Reaches New 52-Week High (CNMD)

NEW YORK ( TheStreet) -- Conmed Corporation (Nasdaq: CNMD) hit a new 52-week high Wednesday as it is currently trading at $29.83, above its previous 52-week high of $29.78 with 16,949 shares traded as of 10:17 a.m. ET. Average volume has been 132,700 shares over the past 30 days.

Conmed has a market cap of $802.1 million and is part of the health care sector and health services industry. Shares are up 14.5% year to date as of the close of trading on Tuesday.

CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The company has a P/E ratio of 25.5, above the average health services industry P/E ratio of 25 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Conmed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Conmed Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss